Kyra Peckaitis joined Dermata as Vice President of Marketing on March 9, 2026, and will oversee marketing strategy, brand development and consumer engagement for the Tome skincare line. She brings experience from Coterie, HubSpot and Sweetgreen to drive go-to-market execution for Dermata’s first consumer products.

As part of her hiring, Peckaitis received a non-qualified option to purchase 15,000 shares of common stock at an exercise price of $1.33 per share, equal to the closing price on her start date. One-fourth of the shares vest on the first anniversary of March 9, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to continued service.

Dermata recently shifted focus from pharmaceutical development to direct-to-consumer skincare and plans to launch its first Tome products mid-2026. Tome will leverage the company’s proprietary Spongilla technology to offer science-driven resurfacing and acne treatments aimed at skincare enthusiasts.